These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18236636)

  • 1. Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model.
    Giordano P; Lorito G; Ciorba A; Martini A; Hatzopoulos S
    Acta Otorhinolaryngol Ital; 2006 Aug; 26(4):198-207. PubMed ID: 18236636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.
    Lorito G; Hatzopoulos S; Laurell G; Campbell KC; Petruccelli J; Giordano P; Kochanek K; Sliwa L; Martini A; Skarzynski H
    Med Sci Monit; 2011 Aug; 17(8):BR179-186. PubMed ID: 21804453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
    Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
    Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
    Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
    Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy.
    Li G; Frenz DA; Brahmblatt S; Feghali JG; Ruben RJ; Berggren D; Arezzo J; Van De Water TR
    Neurotoxicology; 2001 Apr; 22(2):163-76. PubMed ID: 11405249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-methionine provides excellent protection from cisplatin ototoxicity in the rat.
    Campbell KC; Rybak LP; Meech RP; Hughes L
    Hear Res; 1996 Dec; 102(1-2):90-8. PubMed ID: 8951454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
    Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cisplatin ototoxicity in a rat animal model.
    Hatzopoulos S; Di Stefano M; Albertin A; Martini A
    Ann N Y Acad Sci; 1999 Nov; 884():211-25. PubMed ID: 10842595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
    Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
    Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotolerance for cisplatin ototoxicity in the rat.
    Bielefeld EC; Markle A; DeBacker JR; Harrison RT
    Hear Res; 2018 Dec; 370():16-21. PubMed ID: 30253329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action.
    Li G; Sha SH; Zotova E; Arezzo J; Van de Water T; Schacht J
    Lab Invest; 2002 May; 82(5):585-96. PubMed ID: 12003999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate.
    Choe WT; Chinosornvatana N; Chang KW
    Otol Neurotol; 2004 Nov; 25(6):910-5. PubMed ID: 15547419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
    Sockalingam R; Freeman S; Cherny TL; Sohmer H
    Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
    Waissbluth S; Salehi P; He X; Daniel SJ
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity.
    Minami SB; Sha SH; Schacht J
    Hear Res; 2004 Dec; 198(1-2):137-43. PubMed ID: 15567610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
    Watanabe H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
    Bielefeld EC
    Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ototoxicity of 12 mg/kg cisplatin in the Fischer 344/NHsd rat using multiple dosing strategies.
    Harrison RT; Seiler BM; Bielefeld EC
    Anticancer Drugs; 2016 Sep; 27(8):780-6. PubMed ID: 27467178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.